Hunan Er-Kang Pharmaceutical Co (SZSE:300267) Inventories, Work In Process : ¥0 Mil (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Hunan Er-Kang Pharmaceutical Co Inventories, Work In Process?

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Hunan Er-Kang Pharmaceutical Co's work in process for the quarter that ended in Mar. 2025 was ¥0 Mil.

Hunan Er-Kang Pharmaceutical Co Inventories, Work In Process Historical Data

The historical data trend for Hunan Er-Kang Pharmaceutical Co's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Er-Kang Pharmaceutical Co Inventories, Work In Process Chart

Hunan Er-Kang Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Inventories, Work In Process

Get a 7-Day Free Trial

7.24

19.89

21.13

10.98

7.78

Hunan Er-Kang Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Inventories, Work In Process	Get a 7-Day Free Trial															-	12.31	-	7.78	-

Hunan Er-Kang Pharmaceutical Co Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

Hunan Er-Kang Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Er-Kang Pharmaceutical Co Ltd (SZSE:300267) » Definitions » Inventories, Work In Process

Traded in Other Exchanges

N/A

Address

Kangping Road 167, National Economic and Technological Development Zone, Liuyang Changsha, Hunan, CHN, 410331

Website

http://www.hnerkang.com

Hunan Er-Kang Pharmaceutical Co Ltd develops, produces and sells pharmaceutical products in China. The company's main products include pharmaceutical excipients and antibiotics. It offers pharmaceutical excipients, APIs and finished drug products. The pharmaceutical excipients include products such as glycerol, ethanol pharmaceutically, acceptable propylene glycol, sodium hydroxide, and pharmaceutically acceptable sugar. The company's finished drugs primarily include sulbenicillin sodium for injection and compound liquorice tablets. Its APIs include glycerin, dilute hydrochloric acid, dihydroxypropyl theophylline, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. Geographically, all the activities are carried out through China.

Executives

Shuai Fang Wen	Director
Wang Jun Wen	Independent director
Zuo Tian Fang	Independent director
Qi Yang	Supervisors
Li Yi Guo	Supervisors
Chen Wen Xian	Supervisors
Wang Xiang Feng	Directors, executives
Liu Ai Jun	Directors, executives
Luo Lang	Directors, executives
Fan Yi	Securities Affairs Representative
Yang Hai Ming	Directors, executives
Shuai You Wen	Director
Shuai Rui Wen	Director
Gao Zhen Ya	Executives
Cao Zai Yun	Director

Hunan Er-Kang Pharmaceutical Co Headlines

No Headlines